Handelsbanken Fonder AB Takes $1.86 Million Position in Indivior PLC $INDV

Key Points

• Handelsbanken Fonder AB initiated a $1.86 million position in Indivior during the second quarter by purchasing 45,300 shares. Institutional investors and hedge funds collectively own 60.33% of the company.
• Indivior reported quarterly revenue of $343 million and earnings of $5.75 per share, while analysts expect full-year EPS of $3.66. The stock opened at $39.08, with a $4.61 billion market capitalization.
• Analyst sentiment remains positive, with six Buy ratings and one Hold rating producing a “Moderate Buy” consensus and an average price target of $45.17. An executive also bought shares, while the CFO sold 36,000 shares under a pre-arranged trading plan.

Handelsbanken Fonder AB purchased a new position in shares of Indivior PLC (NASDAQ:INDV - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 45,300 shares of the company's stock, valued at approximately $1,859,000.

Several other hedge funds have also bought and sold shares of the company. Quarry LP acquired a new position in Indivior during the third quarter worth approximately $26,000. Raymond James Financial Inc. bought a new position in shares of Indivior during the 2nd quarter worth approximately $26,000. Salomon & Ludwin LLC acquired a new position in shares of Indivior during the 4th quarter worth approximately $30,000. Caitong International Asset Management Co. Ltd lifted its holdings in Indivior by 72.7% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,093 shares of the company's stock valued at $39,000 after purchasing an additional 460 shares during the last quarter. Finally, Rockefeller Capital Management L.P. boosted its position in Indivior by 512.4% during the fourth quarter. Rockefeller Capital Management L.P. now owns 1,286 shares of the company's stock worth $46,000 after purchasing an additional 1,076 shares during the period. 60.33% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Indivior news, CAO Woodrow D. Anderson purchased 1,500 shares of the firm's stock in a transaction on Wednesday, August 5th. The stock was purchased at an average cost of $36.28 per share, for a total transaction of $54,420.00. Following the acquisition, the chief accounting officer owned 26,138 shares in the company, valued at approximately $948,286.64. The trade was a 6.09% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Ryan Preblick sold 36,000 shares of Indivior stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $37.70, for a total value of $1,357,200.00. Following the completion of the transaction, the chief financial officer directly owned 284,751 shares of the company's stock, valued at approximately $10,735,112.70. This trade represents a 11.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.74% of the stock is owned by insiders.

Indivior Trading Up 0.2%

NASDAQ INDV opened at $39.08 on Tuesday. The business's 50-day moving average price is $39.59 and its two-hundred day moving average price is $35.88. Indivior PLC has a 12 month low of $22.22 and a 12 month high of $42.81. The firm has a market capitalization of $4.61 billion, a PE ratio of 14.01 and a beta of 0.86.

Indivior (NASDAQ:INDV - Get Free Report) last announced its earnings results on Tuesday, June 30th. The company reported $5.75 EPS for the quarter. The business had revenue of $343.00 million for the quarter. Indivior had a negative return on equity of 283.11% and a net margin of 26.65%. As a group, analysts forecast that Indivior PLC will post 3.66 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. Craig Hallum reiterated a "buy" rating and issued a $53.00 price target on shares of Indivior in a research note on Tuesday, August 4th. Weiss Ratings upgraded shares of Indivior from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Friday, August 7th. Zacks Research lowered shares of Indivior from a "strong-buy" rating to a "hold" rating in a research report on Monday, June 29th. Finally, Barclays dropped their price objective on shares of Indivior from $46.00 to $43.00 and set an "overweight" rating for the company in a report on Wednesday, August 5th. Six analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $45.17.

About Indivior

Indivior plc is a specialty pharmaceutical company dedicated to developing and delivering treatments for addiction and related mental health disorders. The company's portfolio centers on therapies designed to support individuals dealing with opioid dependence, alcohol use disorder and other behavioral health challenges. Its lead products include Suboxone® (buprenorphine and naloxone) sublingual film and Sublocade® (extended-release buprenorphine) injection, both of which are approved in multiple markets to aid in opioid use disorder management.

Indivior was established in 2014 through a demerger from the pharmaceuticals division of Reckitt Benckiser Group plc, inheriting decades of research and commercial expertise in addiction medicine.

Want to see what other hedge funds are holding INDV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Indivior PLC (NASDAQ:INDV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source